Latest Post

What Compensation is Available for ITP from a Vaccine?

Idiopathic thrombocytopenic purpura (ITP) is a potentially serious blood disorder that has been linked to the measles, mumps and rubella (MMR) vaccines for children and adults. When an MMR vaccine recipient’s ITP results in inpatient treatment or lasts six months or longer, the recipient (or the recipient’s family) may be eligible to file a claim under the National Vaccine Injury Compensation Program (VICP).

Compensation Available Under the VICP for Idiopathic Thrombocytopenic Purpura

The VICP provides compensation to eligible individuals and families who have been diagnosed with ITP caused by an MMR immunization.  Under the terms of the VICP, claimants can seek compensation for three primary categories of losses:

  • Medical Expenses – Claimants can seek compensation for all of the medical expenses incurred in connection with their (or their child’s) ITP. This includes the costs of diagnosis, treatment, prescription medications and medical supplies.
  • Lost Income – Claimants can seek compensation for the loss of income they incur as a result of missing work to seek treatment or being unable to work due to the effects of their ITP. This is true whether they miss work for a few days, a few months or several years.
  • Pain and Suffering – The VICP also provides compensation for claimants’ (or their children’s) pain and suffering, subject to a maximum award of $250,000. “Pain and suffering” describes the non-financial impacts of living with a serious medical condition such as ITP.

Claimants can also obtain compensation for certain other qualifying out-of-pocket costs. Crucially, the National Vaccine Injury Compensation Program pays compensation for eligible claimants’ current and future losses—and claimants’ future losses will far exceed their losses to date in many cases. When seeking compensation for ITP under the VICP, claimants should work closely with their attorneys to ensure that they are calculating their current and future losses correctly.

What About Attorneys’ Fees?

Another important aspect of the VICP is that it pays claimants’ legal fees separately from their awards of financial compensation. So, unlike personal injury cases in which claimants only receive a percentage of their settlement or verdict, in VICP cases claimants receive 100 percent of the amount awarded. Since an experienced attorney will be able to accurately calculate your losses and handle your case in the U.S. Court of Federal Claims (also known as the Vaccine Court) on your behalf, it is strongly recommended that you seek legal representation for your ITP claim.

Note: The information on this page does not apply to COVID-19 vaccines Individuals who are diagnosed with ITP following the receipt of a COVID-19 vaccine are not eligible to file VICP claims but must instead seek compensation under the Countermeasures Injury Compensation Program (CICP).

Speak with Attorney Leah V. Durant About Filing a Vaccine Injury Claim for ITP

If you would like to find out how much you may be able to recover for your (or your child’s) ITP diagnosis resulting from an MMR vaccine, we encourage you to get in touch. To schedule a free initial consultation with attorney Leah V. Durant, please call 202-800-1711 or request an appointment online today.

Leah Durant Bio

Experienced litigation attorney Leah Durant focuses on representing clients in complex vaccine litigation matters. Leah Durant is the owner and principal attorney of the Law Offices of Leah V. Durant, PLLC, a litigation firm based in Washington, DC. Leah Durant and her staff represent clients and their families who suffer from vaccine-related injuries, adverse vaccine reactions and vaccine-related deaths. The Law Offices of Leah V. Durant, PLLC is dedicated to assisting individuals in recovering the highest level of compensation as quickly and efficiently as possible. To learn more, contact vaccine attorney Leah Durant today.

Recent Comments

Juanita on Is the Flu Vaccine Effective a…

Follow Me On Twitter

Find Out More On Social Media